EDITAS MEDICINE, INC. Other Non-Current Liabilities
EDITAS MEDICINE, INC. (EDIT) had Other Non-Current Liabilities of $2.41 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-05
- 2026-06-30: Other Liabilities, Noncurrent $2.41M.
- 2026-03-31: Other Liabilities, Noncurrent $2.87M.
- 2025-12-31: Other Liabilities, Noncurrent $2.81M.
- 2025-09-30: Other Liabilities, Noncurrent $4.69M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $2.41M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $2.87M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $2.81M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $4.69M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $4.59M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $6.36M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $3.07M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $3.28M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $3.77M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $3.47M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.80M 10-K · filed 2025-03-05 | |
| 2022-12-31 | $0.00 10-K · filed 2024-02-28 | |
| 2020-12-31 | $27.50M 10-K · filed 2022-02-24 | |
| 2020-03-31 | $1.00K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $1.00K 10-K · filed 2021-02-26 | |
| 2019-09-30 | $1.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.00K 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $1.00K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $293.00K 10-K · filed 2020-02-26 | |
| 2018-09-30 | $301.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $305.00K 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $311.00K 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $317.00K 10-K · filed 2019-03-01 | |
| 2017-09-30 | $325.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $328.00K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $331.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $396.00K 10-K · filed 2018-03-08 | $16.00K 10-K · filed 2017-03-03 |
| 2016-09-30 | $19.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $21.00K 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $24.00K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $27.00K 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |